Want to stay updated on the latest news?
Create a Reader Account today to follow the industries and companies that interest you, and customize your news dashboard. SIGN INTO READER ACCOUNT CREATE READER ACCOUNT
Global Biotech Partnering Terms and Agreements Analysis Report 2018-2023 with Directory of 6,800+ Deals
March 31, 2023 05:13 ET
|
Research and Markets
Dublin, March 31, 2023 (GLOBE NEWSWIRE) -- The "Global Biotech Partnering Terms and Agreements 2018-2023" report has been added to ResearchAndMarkets.com's offering.The Global Biotech Partnering...
Icosavax Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
March 30, 2023 16:05 ET
|
Icosavax, Inc.
- FDA granted Fast Track Designation for IVX-A12, a bivalent respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) VLP vaccine candidate - - Completed dosing in ongoing Phase 1 study of...
PDS Biotech Announces Plan to Initiate Phase 3 Study Evaluating PDS0101 in Combination with KEYTRUDA® in Head and Neck Cancer in 2023
March 30, 2023 08:00 ET
|
PDS Biotechnology Corporation
FLORHAM PARK, N.J., March 30, 2023 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage immunotherapy company developing a growing pipeline of targeted immunotherapies...
AquaBounty Technologies Announces Retirement of Richard J. Clothier from Board of Directors
March 30, 2023 08:00 ET
|
AquaBounty Technologies, Inc.
MAYNARD, Mass., March 30, 2023 (GLOBE NEWSWIRE) -- AquaBounty Technologies, Inc. (NASDAQ: AQB) (“AquaBounty” or the “Company”), a land-based aquaculture company utilizing technology to enhance...
Mendus presents an update on the use of its DCOne platform to source high-quality NK cell therapies at the 8th Annual Innate Killer Summit
March 30, 2023 02:00 ET
|
Mendus AB
DCONE-DRIVEN EXPANSION OF MEMORY NK CELLS BUILDS THE BASIS FOR NOVEL PROPRIETARY PIPELINE PROGRAM Mendus AB (“Mendus” publ; IMMU.ST), a biopharmaceutical company focused on immunotherapies...
Mendus presenterar en uppdatering vid den 8:e årliga Innate Killer-konferensen avseende användningen av sin DCOne-plattform för att producera terapier baserade på högkvalitativa NK-celler
March 30, 2023 02:00 ET
|
Mendus AB
DCONE-DRIVEN EXPANSION AV MINNES-NK-CELLER LÄGGER GRUNDEN FÖR NYA EGENUTVECKLADE PIPELINEPROGRAM Mendus AB (“Mendus” publ; IMMU.ST), ett bioläkemedelsföretag fokuserat på immunterapier som tar sig...
Psycheceutical Hosts MAPS Founder and Psychedelic Industry Leader Rick Doblin at Its Drug Development Lab
March 29, 2023 13:41 ET
|
Psycheceutical Bioscience, Inc.
Psycheceutical Chief Visionary Officer Zappy Zapolin and CEO Chad Harman with MAPS Founder Rick Doblin MIAMI, March 29, 2023 (GLOBE NEWSWIRE) -- Psycheceutical Bioscience, Inc. ("Psycheceutical"...
Ascorbic Acid Market Size & Share to Surpass $2 Billion by 2030 | Vantage Market Research
March 28, 2023 09:09 ET
|
Vantage Market Research
WASHINGTON, March 28, 2023 (GLOBE NEWSWIRE) -- Global Ascorbic Acid Market is valued at USD 1.4 Billion in 2022 and is projected to reach a value of USD 2 Billion by 2030 at a CAGR (Compound Annual...
Covant and Boehringer Ingelheim Collaborate to Develop a Novel ADAR1 Inhibitor for Use in Cancer Patients
March 28, 2023 08:00 ET
|
Covant Therapeutics
BOSTON, March 28, 2023 (GLOBE NEWSWIRE) -- Covant Therapeutics, an innovative covalent drug discovery company, has entered into an exclusive research collaboration and worldwide licensing agreement...
PDS Biotech Provides Business Update and Reports Fourth-Quarter and Full-Year 2022 Financial Results
March 28, 2023 07:30 ET
|
PDS Biotechnology Corporation
Successful meeting with FDA to discuss registrational pathway for triple combination of PDS0101, PDS0301, and a commercial immune checkpoint inhibitor100% (9/9) clinical response (>60% tumor...